JG
MRNA icon

Joel Greenblatt’s Moderna MRNA Stock Holding History

Joel Greenblatt’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38,774
Closed -$1M – 1790
2025
Q3 		$1M Buy
38,774
+4,792
+14% +$134K ﹤0.01% 1201
2025
Q2 		$938K Buy
+33,982
New +$895K 0.01% 1149
2025
Q1 		– Sell
-64,220
Closed -$2.67M – 1626
2024
Q4 		$2.67M Buy
+64,220
New +$3.07M 0.03% 648
2024
Q3 		– Sell
-67,402
Closed -$8M – 1487
2024
Q2 		$8M Sell
67,402
-4,408
-6% -$558K 0.1% 266
2024
Q1 		$7.65M Buy
71,810
+5,708
+9% +$575K 0.12% 224
2023
Q4 		$6.57M Buy
66,102
+39,210
+146% +$3.3M 0.12% 201
2023
Q3 		$2.78M Sell
26,892
-11,837
-31% -$1.32M 0.06% 457
2023
Q2 		$4.71M Sell
38,729
-37,978
-50% -$5.07M 0.1% 256
2023
Q1 		$11.8M Sell
76,707
-3,835
-5% -$633K 0.29% 39
2022
Q4 		$14.5M Sell
80,542
-45,440
-36% -$7.43M 0.41% 22
2022
Q3 		$14.9M Buy
125,982
+51,126
+68% +$7.76M 0.45% 18
2022
Q2 		$10.7M Buy
74,856
+532
+0.7% +$76K 0.34% 42
2022
Q1 		$12.8M Buy
74,324
+45,753
+160% +$7.7M 0.4% 27
2021
Q4 		$7.26M Buy
28,571
+18,075
+172% +$5.28M 0.23% 92
2021
Q3 		$4.04M Buy
+10,496
New +$3.87M 0.16% 179
2021
Q2 		– Sell
-1,829
Closed -$240K – 1059
2021
Q1 		$240K Sell
1,829
-3,962
-68% -$574K 0.01% 899
2020
Q4 		$605K Sell
5,791
-122
-2% -$12.3K 0.02% 668
2020
Q3 		$418K Sell
5,913
-246
-4% -$17.2K 0.01% 769
2020
Q2 		$395K Sell
6,159
-1,496
-20% -$81.9K 0.01% 803
2020
Q1 		$229K Buy
+7,655
New +$176K 0.01% 907

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Joel Greenblatt's MRNA Position: Q4 2025 in Review

Joel Greenblatt sold out of Moderna (MRNA) in Q4 2025, closing a stake of 38,774 shares — an estimated $1M sold.

Joel Greenblatt first reported a position in MRNA in Q1 2020 and held it in 20 quarters. The position peaked at $14.9M in Q3 2022. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Joel Greenblatt reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Joel Greenblatt sold 38,774 Moderna shares in Q4 2025, an estimated $1M.
  • Joel Greenblatt first reported a position in Moderna in Q1 2020 and held it in 20 quarters.
  • Joel Greenblatt's Moderna position peaked at $14.9M in Q3 2022.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Gotham Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.